3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Uterine Cervical Neoplasms
2
Oropharyngeal Neoplasms
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Plasma Cell
1
Glioma
1
Disease
1
Carcinoma, Squamous Cell
1
Interventions
Rituximab
15
Cyclophosphamide
15
Prednisone
11
Doxorubicin
10
Vincristine
7
Lenalidomide
7
ibrutinib
6
polatuzumab vedotin
4
obinutuzumab
4
glofitamab
4
fludarabine
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
venetoclax
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
pembrolizumab
2
deltacortene
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Fluorodeoxyglucose F18
×
30 days
×
Clear all
No trials found.